Scilex Holding SCLX
NASDAQ SCLX
$4.06 -0.34 (-7.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Return on Sales [ROS] (2022 - 2026)

Updated

Scilex Holding's Return on Sales [ROS] was -385.02% in Q2 2026, down 177.88 percentage points from -207.14% a year earlier and down 11.16 percentage points from the prior quarter.

Analysis

Scilex Holding (SCLX) Return on Sales [ROS] (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Scilex Holding's Return on Sales [ROS] was -1134.81% through Jun 30, 2026, down 916.28 percentage points year-over-year; for FY2025, it came in at -1141.94%, down 994.59 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -992.29 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -147.34% in FY2024 (+78.21 pp), -225.55% in FY2023 (-92.43 pp), -133.13% in FY2022 (-18.69 pp) and -114.44% in FY2021 (+35.22 pp).
  • Quarterly Return on Sales [ROS] has moved between -2295.25% (Q4 2025) and -93.31% (Q3 2022) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in two of the last eight quarters, with an average year-over-year change of -503.27 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2024 (a gain of 245.59 percentage points); the worst was Q4 2025 (a drop of 2104.92 percentage points).
  • Per Business Quant data, SCLX's Return on Sales [ROS] in the three quarters before Q2 2026 was -373.85% (Q1 2026), -2295.25% (Q4 2025) and -1766.21% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Scilex Holding 31.02 Mn 19.00 Mn 3.97 Mn -385.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -385.02%
Mar 31, 2026 -373.85%
Dec 31, 2025 -2,295.25%
Sep 30, 2025 -1,766.21%
Jun 30, 2025 -207.14%
Mar 31, 2025 -557.51%
Dec 31, 2024 -190.33%
Sep 30, 2024 -137.97%
Jun 30, 2024 -95.44%
Mar 31, 2024 -178.96%
Dec 31, 2023 -136.23%
Sep 30, 2023 -383.56%
Jun 30, 2023 -181.32%
Mar 31, 2023 -240.72%
Dec 31, 2022 -165.63%
Sep 30, 2022 -93.31%
Jun 30, 2022 -144.73%
Mar 31, 2022 -129.27%
API Access

Scilex Holding Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SCLX&period=max&api_key=YOUR_API_KEY